Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. (See Exhibit 1.)
Exhibit 1
Device/Diagnostics Quarterly Deal Statistics, Q1 2014
A look at financing, M&A, and alliance activity, January–March 2014
Device financing dropped more than 40% to $714 million in Q1; Smith & Nephew’s $1.7 billion acquisition of ArthroCare overshadowed acquisitions. Diagnostics companies raised $568 million, a 34% increase over 2013’s final quarter; nonprofits provided assets to diagnostics firms in multiple licensing arrangements.